WEDNESDAY, July 23, 2025 (HealthDay News) -- Glucagon-like peptide 1 receptor agonists (GLP-1 RAs) are associated with reduced type 2 diabetes mellitus (T2DM)-related dementia risk compared with metformin, according to a study published online July 22 in BMJ Open Diabetes Research & Care.Mingyang Sun, from the People's Hospital of Zhengzhou University in China, and colleagues conducted a retrospective cohort study using data from a global health research network between 2004 and 2024 to examine the comparative effectiveness of GLP-1 RAs and metformin in reducing dementia risk
Mechanistic rationale and next steps Jones said the observed benefit is likely multifactorial
An effective fat-loss tool typically influences at least one of these directly: BPC-157 has not been established as reliably effective in humans for any of those categories of fat loss
For you, if you want help to stay mentally & physically refreshed & energized Creatine & Acetyl-L-Carnitine Energy Plus can: Support healthy cognitive function Help fight physical & mental fatigue Promote lean muscle mass & exercise performance Encourage healthy cellular energy metabolism Handling your most demanding mental and physical tasks can require an extra boost
Our new program, the Mayo Clinic Diet for Weight-Loss Medications, can support your journey
H.RipaR
